Evidence map›Paper›PMID 40940820›Full record

ArticleCancers2025

Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma in Patients with Stable Disease, Minor Response or Partial Response and Disease in Bone or Bone Marrow: Systematic Review and Matching-Adjusted Indirect Comparison.

Holger N Lode, Przemysław Holko, Aleksandra Wieczorek, Nikolai Siebert, Dominique Valteau-Couanet, Alberto Garaventa, Adela Cañete, John Anderson, Isaac Yaniv, Shifra Ash and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Holger N LodeDepartment of Pediatric Hematology and Oncology, University Medicine Greifswald, 17489 Greifswald, Germany.ORCID 0000-0002-1201-208X
Przemysław HolkoDepartment of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, 31-008 Krakow, Poland.ORCID 0000-0002-6821-4078
Aleksandra WieczorekPaediatric Haematology Oncology, Jagiellonian University Medical College, 31-008 Krakow, Poland.ORCID 0000-0001-6750-2628
Nikolai SiebertDepartment of Pediatric Hematology and Oncology, University Medicine Greifswald, 17489 Greifswald, Germany.ORCID 0000-0001-6254-1302
Dominique Valteau-CouanetChildren and Adolescent Oncology Department, Gustave Roussy, Paris-Sud University, 94805 Paris, France.
Alberto GaraventaOncology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
Adela CañeteHospital Universitario y Politecnico La Fe, 46026 Valencia, Spain.ORCID 0000-0002-5669-5097
John AndersonUCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
Isaac YanivSchneider Children's Medical Center of Israel, Sackler Faculty of Medicine Tel Aviv University, Petach Tikva 4920235, Israel.
Shifra AshDepartment of Pediatric Hematology-Oncology, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Technion-Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa 3109601, Israel.
Juliet GrayCentre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, UK.
Roberto LukschFondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Carla ManzittiOncology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
Sascha Troschke-MeurerDepartment of Pediatric Hematology and Oncology, University Medicine Greifswald, 17489 Greifswald, Germany.ORCID 0000-0002-6185-462X
Torsten EbelingDepartment of Pediatric Hematology and Oncology, University Medicine Greifswald, 17489 Greifswald, Germany.
Paweł KawalecDepartment of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, 31-008 Krakow, Poland.
Katarzyna ŚladowskaDepartment of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, 31-008 Krakow, Poland.
Ruth L LadensteinDepartment of Paediatrics, St. Anna Children's Hospital, Medical University, 1090 Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dinutuximab betamatching-adjusted indirect comparisonnaxitamabrelapsed/refractory neuroblastomasystematic review

Identifiers

PMID40940820
PMCPMC12427561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.